Vyacheslav Pronin

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue et al. · The Lancet Diabetes & Endocrinology · 2014 · 402 citations

Medicine, Endocrinology, Pharmacotherapy +4

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients

Liliya Rostomyan, Adrian Daly, Patrick Pétrossians et al. · Endocrine Related Cancer · 2015 · 202 citations · Full text

Medicine, Endocrinology, Endocrine Genetics +16

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

Sebastian JCMM Neggers, Vyacheslav Pronin, Inga Balcere et al. · European Journal of Endocrinology · 2015 · 54 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

The results of analysis of the major epidemiological characteristics of primary hyperparathyroidism in Russia based on the registry data

Natalia Mokrysheva, Elena Viktorovna Peretokina, Vyacheslav Pronin · Problems of Endocrinology · 2012 · 17 citations · Full text

Medicine, Endocrinology, Pathology +10

Guidelines on diagnostics and treatment of acromegaly (draft)

Elena Przhiyalkovskaya, G. А. Melnichenko, L I Astafieva et al. · Obesity and metabolism · 2024 · 11 citations · Full text

Medicine, Endocrinology, Internal Medicine +17